Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at ...

Those with Ashkenazi Jewish ancestry have a one in 40 chance of carrying a BRCA1 or BRCA2 compared to a one in 250 chance for ...

More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women. "Not enough men are getting ...

Research shows that the breast cancer gene 1 (BRCA1) not only pushes accurate DNA repair to guard against cancer but promotes subsequent activity in tumor suppression. A new study led by The ...

I've stopped waiting to feel like the person I was before cancer and started embracing the person I became afterwards.

Metaplastic breast cancer (MpBC) is an aggressive malignancy characterized by the presence of two or more cell types, most commonly an admixture of epithelial and mesenchymal elements [1]. MpBC is a ...

Harmful variants in the BRCA1 gene greatly increase a person's lifetime risk of developing breast, ovarian and pancreatic cancers, but most people are unaware they are carriers. In a new study in the ...

Men with BRCA1/2 genetic mutations have elevated risks for prostate, pancreatic, and breast cancers, yet recommendations for screening and risk assessment are unknown. Referral patterns reveal ...

Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at ...

Sign up for Being Human, a newsletter that explores wellness culture, mortality and disease, and other mysteries of the body and the mind. “It’s a branding ...

Patients with BRCA1/2-associated breast cancer have good survival outcomes and are living longer, but this raises the question of their risk for secondary primary cancers. In a risk-assessment study, ...

More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women. According to a July 25 JAMA ...